Profile
Blue Ox Healthcare Partners is a growth equity firm based in New York, founded in 2009. The firm specializes in healthcare investments, focusing on technology-enabled innovations that drive precision health. With a team of five professionals, Blue Ox leverages its deep industry knowledge to guide companies through the commercialization process, aiming to improve healthcare outcomes by addressing patients as individuals.
The firm invests in growth-stage companies within the healthcare services, health technology, and life sciences sectors. Blue Ox targets commercial-ready innovations in precision health, healthcare delivery, and affordability. They typically invest in companies that are ready to scale, providing both capital and strategic guidance. The firm manages Blue Ox Healthcare Partners Fund 1, which has an AUM of $50 million.
Notable investments by Blue Ox include Sera Prognostics, a proteomic diagnostic platform; Epic Sciences, a liquid biopsy platform; and Gemelli Biotech, which focuses on precision diagnostics for GI diseases. These investments reflect Blue Ox's commitment to advancing healthcare technologies that offer significant improvements in patient care and cost management.
Industry
Blue Ox Healthcare Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Blue Ox Healthcare Partners Fund 1
|
Venture Capital (VC)
|
Healthcare Services
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$50 M
|
December 2009
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.